Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Limosilactobacillus reuteri has shown anti-obesity and anti-inflammatory effects in previous studies (1)
It is a randomized, double-blind, placebo-controlled trial studying Limosilactobacillus reuteri LR-99 (3 × 10^10 CFUs/sachet) or maltodextrin (placebo) in 71 enrolled patients with Prader-Willi syndrome (PWS) twice a day of either probiotics or placebo for a duration of 12 weeks (1)
BMI, psychological questionnaires (1)
The trial revealed a significant reduction in BMI for the Limosilactobacillus reuteri LR-99 group at both 6 weeks and 12 weeks compared to the baseline, with statistical significance (P < …